4.6 Article

Phospho-valproic acid (MDC-1112) reduces pancreatic cancer growth in patient-derived tumor xenografts and KPC mice: enhanced efficacy when combined with gemcitabine

相关参考文献

注意:仅列出部分参考文献,下载原文获取全部文献信息。
Article Oncology

MTOR inhibitor-based combination therapies for pancreatic cancer

Zonera Hassan et al.

BRITISH JOURNAL OF CANCER (2018)

Article Biochemistry & Molecular Biology

Interleukin-6 promotes pancreatic cancer cell migration by rapidly activating the small GTPase CDC42

Gina L. Razidlo et al.

JOURNAL OF BIOLOGICAL CHEMISTRY (2018)

Article Biochemistry & Molecular Biology

A novel tricarbonylmethane agent (CMC2.24) reduces human pancreatic tumor growth in mice by targeting Ras

Naveen A. Mallangada et al.

MOLECULAR CARCINOGENESIS (2018)

Review Biochemistry & Molecular Biology

Role of Epithelial-Mesenchymal Transition in Tumor Progression

N. A. Gloushankova et al.

BIOCHEMISTRY-MOSCOW (2018)

Article Biochemistry & Molecular Biology

Downregulation of STAT3/NF-B potentiates gemcitabine activity in pancreatic cancer cells

Jingjing Gong et al.

MOLECULAR CARCINOGENESIS (2017)

Article Oncology

A central role for cadherin signaling in cancer

Antonis Kourtidis et al.

EXPERIMENTAL CELL RESEARCH (2017)

Review Oncology

Chemoresistance in pancreatic cancer: Emerging concepts

Manu Gnanamony et al.

ONCOLOGY LETTERS (2017)

Review Biochemistry & Molecular Biology

Mitochondrial Stat3, the Need for Design Thinking

Rui Yang et al.

INTERNATIONAL JOURNAL OF BIOLOGICAL SCIENCES (2016)

Review Medicine, General & Internal

Pancreatic cancer

Terumi Kamisawa et al.

LANCET (2016)

Article Medicine, General & Internal

Pancreatic cancer

Jorg Kleeff et al.

NATURE REVIEWS DISEASE PRIMERS (2016)

Review Cell Biology

GEMMs as preclinical models for testing pancreatic cancer therapies

Aarthi Gopinathan et al.

DISEASE MODELS & MECHANISMS (2015)

Article Medicine, General & Internal

Increased Survival in Pancreatic Cancer with nab-Paclitaxel plus Gemcitabine

Daniel D. Von Hoff et al.

NEW ENGLAND JOURNAL OF MEDICINE (2013)

Article Oncology

EGF Receptor Is Required for KRAS-Induced Pancreatic Tumorigenesis

Christine M. Ardito et al.

CANCER CELL (2012)

Review Gastroenterology & Hepatology

Developments in metastatic pancreatic cancer: Is gemcitabine still the standard?

Jie-Er Ying et al.

WORLD JOURNAL OF GASTROENTEROLOGY (2012)

Article Oncology

Phospho-Sulindac (OXT-328) Combined with Difluoromethylornithine Prevents Colon Cancer in Mice

Gerardo G. Mackenzie et al.

CANCER PREVENTION RESEARCH (2011)

Article Oncology

STAT3 Plays a Critical Role in KRAS-Induced Pancreatic Tumorigenesis

Ryan B. Corcoran et al.

CANCER RESEARCH (2011)

Article Medicine, General & Internal

FOLFIRINOX versus Gemcitabine for Metastatic Pancreatic Cancer

Thierry Conroy et al.

NEW ENGLAND JOURNAL OF MEDICINE (2011)

Article Gastroenterology & Hepatology

Phospho-Sulindac (OXT-328), a Novel Sulindac Derivative, Is Safe and Effective in Colon Cancer Prevention in Mice

Gerardo G. Mackenzie et al.

GASTROENTEROLOGY (2010)

Article Multidisciplinary Sciences

Signal Transducer and Activator of Transcription-3, Inflammation, and Cancer How Intimate Is the Relationship?

Bharat B. Aggarwal et al.

NATURAL COMPOUNDS AND THEIR ROLE IN APOPTOTIC CELL SIGNALING PATHWAYS (2009)

Review Medicine, Research & Experimental

Biomarkers for epithelial-mesenchymal transitions

Michael Zeisberg et al.

JOURNAL OF CLINICAL INVESTIGATION (2009)

Article Oncology

Src continues aging: Current and future clinical directions

Scott Kopetz et al.

CLINICAL CANCER RESEARCH (2007)

Article Biochemical Research Methods

Clonogenic assay of cells in vitro

Nicolaas A. P. Franken et al.

NATURE PROTOCOLS (2006)